Observational Study
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2017; 23(22): 4080-4089
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4080
Observation of the effect of targeted therapy of 64-slice spiral CT combined with cryoablation for liver cancer
Qiao-Huan Yan, Dian-Guo Xu, Yan-Feng Shen, Ding-Ling Yuan, Jun-Hui Bao, Hai-Bin Li, Ying-Gang Lv
Qiao-Huan Yan, Department of Geriatrics, the First Hospital of Handan, Handan 056001, Hebei Province, China
Dian-Guo Xu, Department of Anatomy, Medical College of Hebei University of Engineering, Handan 056001, Hebei Province, China
Yan-Feng Shen, Hai-Bin Li, Department of Oncology, Affiliated Hospital of Hebei University of Engineering, Handan 056001, Hebei Province, China
Ding-Ling Yuan, Jun-Hui Bao, Ying-Gang Lv, Department of Imaging, Affiliated Hospital of Hebei Medical University, Shijiazhuang 056002, Hebei Province, China
Ying-Gang Lv, Department of Radiology, Affiliated Hospital of Hebei University of Engineering, Handan 056001, Hebei Province, China
Author contributions: Yan QH and Lv YG contributed equally to this work; Yan QH, Xu DG, Shen YF, Yuan DL, Bao JH, Li HB and Lv YG designed research; Yan QH, Yuan DL, Bao JH, Li HB and Lv YG performed research; Yan QH, Xu DG, Shen YF, Li HB and Lv YG contributed new reagents/analytic tools; Yan QH, Xu DG, Shen YF and Lv YG analyzed data; and Yan QH and Lv YG wrote the paper.
Supported by Hebei Province Health Department of Scientific Research Fund Project, No. 20110157.
Institutional review board statement: The study was reviewed and approved by the Affiliated Hospital of Hebei University of Engineering Institutional Review Board.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors have no conflict of interest related to the manuscript.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Ying-Gang Lv, Deputy Chief Physician, Department of Radiology, Affiliated Hospital of Hebei University of Engineering, Jianshe Street No. 80, Fuxing District, Handan 056001, Hebei Province, China. lvyinggang@126.com
Telephone: +86-310-8577555 Fax: +86-310-8577555
Received: December 10, 2016
Peer-review started: December 12, 2016
First decision: December 29, 2016
Revised: February 15, 2017
Accepted: March 4, 2017
Article in press: March 4, 2017
Published online: June 14, 2017
Processing time: 185 Days and 15.1 Hours
Abstract
AIM

To observe the effect of targeted therapy with 64-slice spiral computed tomography (CT) combined with cryoablation for liver cancer.

METHODS

A total of 124 patients (142 tumors) were enrolled into this study. According to the use of dual-slice spiral CT or 64-slice spiral CT as a guide technology, patients were divided into two groups: dual-slice group (n = 56, 65 tumors) and 64-slice group (n = 8, 77 tumors). All patients were accepted and received targeted therapy by an argon-helium superconducting surgery system. The guided scan times of the two groups was recorded and compared. In the two groups, the lesion ice coverage in diameter of ≥ 3 cm and < 3 cm were recorded, and freezing effective rate was compared. Hepatic perfusion values [hepatic artery perfusion (HAP), portal vein perfusion (PVP), and the hepatic arterial perfusion index (HAPI)] of tumor tissues, adjacent tissues and normal liver tissues at preoperative and postoperative four weeks in the two groups were compared. Local tumor changes were recorded and efficiency was compared at four weeks post-operation. Adverse events were recorded and compared between the two groups, including fever, pain, frostbite, nausea, vomiting, pleural effusion and abdominal bleeding.

RESULTS

Guided scan times in the dual-slice group was longer than that in the 64-slice group (t = 11.445, P = 0.000). The freezing effective rate for tumors < 3 cm in diameter in the dual-slice group (81.58%) was lower than that in the 64-slice group (92.86%) (χ2 = 5.707, P = 0.017). The HAP and HAPI of tumor tissues were lower at four weeks post-treatment than at pre-treatment in both groups (all P < 0.05), and those in the 64-slice group were lower than that in the dual-slice group (all P < 0.05). HAP and PVP were lower and HAPI was higher in tumor adjacent tissues at post-treatment than at pre-treatment (all P < 0.05). Furthermore, the treatment effect and therapeutic efficacy in the dual-slice group were lower than the 64-slice group at four weeks post-treatment (all P < 0.05). Moreover, pleural effusion and intraperitoneal hemorrhage occurred in patients in the dual-slice group, while no complications occurred in the 64-slice group (all P < 0.05).

CONCLUSION

64-slice spiral CT applied with cryoablation in targeted therapy for liver cancer can achieve a safe and effective freezing treatment, so it is worth being used.

Keywords: 64-slice spiral computed tomography; Cryoablation; Liver cancer

Core tip: One hundred and twenty-four patients with liver cancer were accepted therapy by argon-helium superconducting surgery system. Compared with 64-row group, guided scan times was longer and freezing effective rate for tumors < 3 cm was lower in the dual-slice group. Four weeks after treatment, compared with dual-slice group, the hepatic artery perfusion and hepatic arterial perfusion index of tumor tissues were lower, the treatment effect and therapeutic efficacy in the 64-row group were higher. Complications were higher in the double-row group than in the 64-row group. 64-slice spiral computed tomography applied with cryoablation in targeted therapy for liver cancer can achieve a safe and effective freezing treatment.